Levadura Biotechnology has received the International Search Report (ISR) for Levadura’s first Patent Cooperation Treaty (PCT) patent application. The examiner identified multiple subject matters that were both novel and inventive. This examination is an important step in obtaining intellectual property protection for Levadura’s cannabinoid biosynthesis technology.
"Today marks a critical milestone in Levadura’s establishment as the only company using vegetable oil as a raw material to produce cannabinoids,” Levadura CEO, Matthew Engler, said. “This review, combined with Levadura’s recent proof-of-concept for two of the most important cannabinoids using our proprietary technology are a testament to the scientific pedigree and hard work of our team. This revolutionary technology will make Levadura the go-to source for cannabinoids across multiple applications, including those with the lowest cost and highest quality requirements."
"This first application protects our core technology. We are looking forward to interacting with the US Patent Office to quickly prosecute and obtain patent protection,” Levadura CTO, José M. Laplaza, said.
The Company’s next step is to prosecute the patent with the USPTO. The US is the largest cannabinoid market in the world, with an expected size of $100 billion by the year 2029.